SEC Company Response from Emergent BioSolutions Inc. (EBS) (CIK 0001367644) (EBS) — Dec 22, 2014
Emergent BioSolutions Inc. (EBS) (CIK 0001367644)
Date: Dec. 22, 2014 · CIK: 0001367644 · Accession: 0001367644-14-000050
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-33137
Referenced dates: December 16, 2014
Letter
RE:
December 22, 2014
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Scott Wuenschell, Staff Accountant
Emergent BioSolutions Inc.
Form 10-K for the Fiscal Year Ended December 31, 2013
Filed March 10, 2014
Form 10-Q for the Quarterly Period Ended September 30, 2014
Filed November 10, 2014
File No. 001-33137
Mr. Wuenschell:
Emergent BioSolutions Inc. (the "Company") is sending this letter to confirm the extension of time within which it will respond to the Staff's comment letter dated December 16, 2014, relating to the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. As agreed, the Company will file its written response to the Staff's comment letter by no later than January 15, 2015.
If you have any questions, or require any additional information, please contact Michael Darling, Vice President, Finance and Administration at (301) 795-1865. Thank you for your assistance.
Regards,
By: /S/ ROBERT G. KRAMER
Show Raw Text
CORRESP
1
filename1.htm
December 22, 2014
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Scott Wuenschell, Staff Accountant
RE:
Emergent BioSolutions Inc.
Form 10-K for the Fiscal Year Ended December 31, 2013
Filed March 10, 2014
Form 10-Q for the Quarterly Period Ended September 30, 2014
Filed November 10, 2014
File No. 001-33137
Mr. Wuenschell:
Emergent BioSolutions Inc. (the "Company") is sending this letter to confirm the extension of time within which it will respond to the Staff's comment letter dated December 16, 2014, relating to the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. As agreed, the Company will file its written response to the Staff's comment letter by no later than January 15, 2015.
If you have any questions, or require any additional information, please contact Michael Darling, Vice President, Finance and Administration at (301) 795-1865. Thank you for your assistance.
Regards,
By: /S/ ROBERT G. KRAMER
Robert G. Kramer
Executive Vice President,
Chief Financial Officer and Treasurer
CC: Joel Parker, Accounting Branch Chief
Jim B. Rosenberg, Senior Assistant Chief Accountant